US Stock MarketDetailed Quotes

OLMA Olema Pharmaceuticals

Watchlist
  • 12.300
  • -0.200-1.60%
Close Jul 12 16:00 ET
  • 12.300
  • 0.0000.00%
Post 16:02 ET
687.99MMarket Cap-6150P/E (TTM)

Olema Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
16.00%34.34M
-1.89%104.96M
11.75%30.42M
0.52%23.34M
-35.12%21.6M
27.30%29.6M
49.65%106.99M
25.10%27.22M
30.74%23.22M
101.51%33.29M
Selling and administrative expenses
-34.24%4.46M
-23.84%18.82M
-19.36%4.54M
-30.49%3.89M
-42.11%3.61M
-6.47%6.78M
21.20%24.71M
-2.54%5.64M
6.80%5.6M
35.28%6.24M
-General and administrative expense
-34.24%4.46M
-23.84%18.82M
-19.36%4.54M
-30.49%3.89M
-42.11%3.61M
-6.47%6.78M
21.20%24.71M
-2.54%5.64M
6.80%5.6M
35.28%6.24M
Research and development costs
30.92%29.88M
4.70%86.14M
19.87%25.87M
10.36%19.45M
-33.51%17.99M
42.58%22.83M
61.01%82.27M
35.11%21.58M
40.76%17.63M
127.15%27.05M
Operating profit
-16.00%-34.34M
1.89%-104.96M
-11.75%-30.42M
-0.52%-23.34M
35.12%-21.6M
-27.30%-29.6M
-49.65%-106.99M
-25.10%-27.22M
-30.74%-23.22M
-101.51%-33.29M
Net non-operating interest income expense
156.86%3.35M
273.65%8.33M
264.95%3.55M
208.52%1.92M
273.49%1.55M
498.62%1.31M
404.07%2.23M
792.66%973K
492.38%622K
254.70%415K
Non-operating interest income
156.86%3.35M
273.65%8.33M
264.95%3.55M
208.52%1.92M
273.49%1.55M
498.62%1.31M
404.07%2.23M
792.66%973K
492.38%622K
254.70%415K
Other net income (expense)
54.55%17K
29.63%-19K
38.81%93K
34.17%-79K
-320.00%-44K
83.33%11K
42.55%-27K
570.00%67K
-114.29%-120K
2,100.00%20K
Other non- operating income (expenses)
54.55%17K
29.63%-19K
38.81%93K
34.17%-79K
-320.00%-44K
83.33%11K
42.55%-27K
570.00%67K
-114.29%-120K
2,100.00%20K
Income before tax
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
Income tax
Net income
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
Net income continuous Operations
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
Minority interest income
Net income attributable to the parent company
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
Basic earnings per share
20.00%-0.56
18.32%-2.14
26.15%-0.48
15.79%-0.48
40.24%-0.49
-20.69%-0.7
-45.56%-2.62
-20.37%-0.65
-26.67%-0.57
-95.24%-0.82
Diluted earnings per share
20.00%-0.56
18.32%-2.14
26.15%-0.48
15.79%-0.48
40.24%-0.49
-20.69%-0.7
-45.56%-2.62
-20.37%-0.65
-26.67%-0.57
-95.24%-0.82
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 16.00%34.34M-1.89%104.96M11.75%30.42M0.52%23.34M-35.12%21.6M27.30%29.6M49.65%106.99M25.10%27.22M30.74%23.22M101.51%33.29M
Selling and administrative expenses -34.24%4.46M-23.84%18.82M-19.36%4.54M-30.49%3.89M-42.11%3.61M-6.47%6.78M21.20%24.71M-2.54%5.64M6.80%5.6M35.28%6.24M
-General and administrative expense -34.24%4.46M-23.84%18.82M-19.36%4.54M-30.49%3.89M-42.11%3.61M-6.47%6.78M21.20%24.71M-2.54%5.64M6.80%5.6M35.28%6.24M
Research and development costs 30.92%29.88M4.70%86.14M19.87%25.87M10.36%19.45M-33.51%17.99M42.58%22.83M61.01%82.27M35.11%21.58M40.76%17.63M127.15%27.05M
Operating profit -16.00%-34.34M1.89%-104.96M-11.75%-30.42M-0.52%-23.34M35.12%-21.6M-27.30%-29.6M-49.65%-106.99M-25.10%-27.22M-30.74%-23.22M-101.51%-33.29M
Net non-operating interest income expense 156.86%3.35M273.65%8.33M264.95%3.55M208.52%1.92M273.49%1.55M498.62%1.31M404.07%2.23M792.66%973K492.38%622K254.70%415K
Non-operating interest income 156.86%3.35M273.65%8.33M264.95%3.55M208.52%1.92M273.49%1.55M498.62%1.31M404.07%2.23M792.66%973K492.38%622K254.70%415K
Other net income (expense) 54.55%17K29.63%-19K38.81%93K34.17%-79K-320.00%-44K83.33%11K42.55%-27K570.00%67K-114.29%-120K2,100.00%20K
Other non- operating income (expenses) 54.55%17K29.63%-19K38.81%93K34.17%-79K-320.00%-44K83.33%11K42.55%-27K570.00%67K-114.29%-120K2,100.00%20K
Income before tax -9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M-100.28%-32.86M
Income tax
Net income -9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M-100.28%-32.86M
Net income continuous Operations -9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M-100.28%-32.86M
Minority interest income
Net income attributable to the parent company -9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M-100.28%-32.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M-100.28%-32.86M
Basic earnings per share 20.00%-0.5618.32%-2.1426.15%-0.4815.79%-0.4840.24%-0.49-20.69%-0.7-45.56%-2.62-20.37%-0.65-26.67%-0.57-95.24%-0.82
Diluted earnings per share 20.00%-0.5618.32%-2.1426.15%-0.4815.79%-0.4840.24%-0.49-20.69%-0.7-45.56%-2.62-20.37%-0.65-26.67%-0.57-95.24%-0.82
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg